Evidence map›Paper›PMID 26556379›Full record

ReviewMembranes2015

Challenges in Commercializing Biomimetic Membranes.

Mark Perry, Steen Ulrik Madsen, Tine Jørgensen, Sylvie Braekevelt, Karsten Lauritzen, Claus Hélix-Nielsen

Abstract readReview
In one paragraph

Review in Membranes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mark PerryAquaporin Asia, 1 Clean Tech Loop, CleanTech One #03-05, Singapore 63714, Singapore. mpe@aquaporin.asia.
Steen Ulrik MadsenAquaporin A/S, Ole Maaløes Vej 3, Copenhagen N DK2200, Denmark. sum@aquaporin.dk.
Tine JørgensenAquaporin A/S, Ole Maaløes Vej 3, Copenhagen N DK2200, Denmark. tjo@aquaporin.dk.
Sylvie BraekeveltAquaporin A/S, Ole Maaløes Vej 3, Copenhagen N DK2200, Denmark. sbr@aquaporin.dk.
Karsten LauritzenDSS, A Tetra Pak Company, Bergsøesvej 17, Silkeborg DK-8600, Denmark. Karsten.Lauritzen@tetrapak.com.
Claus Hélix-NielsenAquaporin A/S, Ole Maaløes Vej 3, Copenhagen N DK2200, Denmark. clhe@env.dtu.dk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The discovery of selective water channel proteins-aquaporins-has prompted growing interest in using these proteins, as the building blocks for designing new types of membranes. However, as with any other new and potentially disruptive technology, barriers for successful market entry exist. One category includes customer-related barriers, which can be influenced to some extent. Another category includes market-technical-related barriers, which can be very difficult to overcome by an organization/company aiming at successfully introducing their innovation on the market-in particular if both the organization and the technology are at early stages. Often, one faces barriers from both these categories at the same time, which makes it necessary to gain insight of the particular market when introducing a new innovative product. In this review we present the basic concepts and discuss some of these barriers and challenges associated with introducing biomimetic aquaporin membranes. These include technical issues in membrane production and product testing. Then we discuss possible business models for introducing new technologies in general, followed by a presentation of beach-head market segments relevant for biomimetic aquaporin membranes.

Indexed as

aquaporin membranesbiomimeticscommercializationearly stage technology

Identifiers

PMID26556379
PMCPMC4704006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.